发布求助
文献互助 智能选刊 最新文献

Medizinische Genetik最新文献

筛选
英文 中文
New horizons in human genetics - a call for submissions on trailblazing topics. 人类遗传学的新视野-呼吁提交开创性主题。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3005
{"title":"New horizons in human genetics - a call for submissions on trailblazing topics.","authors":"","doi":"10.1515/medgen-2026-3005","DOIUrl":"10.1515/medgen-2026-3005","url":null,"abstract":"","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"243"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
50 Jahre Humangenetik am Universitätsklinikum Essen. 人类遗传学50年。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3003
Frank Kaiser, Eberhard Passarge, Bernhard Horsthemke
{"title":"50 Jahre Humangenetik am Universitätsklinikum Essen.","authors":"Frank Kaiser, Eberhard Passarge, Bernhard Horsthemke","doi":"10.1515/medgen-2026-3003","DOIUrl":"10.1515/medgen-2026-3003","url":null,"abstract":"","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"253-256"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic risk scores: en route to clinical practice. 多基因风险评分：正在走向临床实践。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3022
Markus M Nöthen, Johannes Schumacher
{"title":"Polygenic risk scores: en route to clinical practice.","authors":"Markus M Nöthen, Johannes Schumacher","doi":"10.1515/medgen-2026-3022","DOIUrl":"10.1515/medgen-2026-3022","url":null,"abstract":"","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"153-156"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic scores in psychiatric research and clinical practice. 多基因评分在精神病学研究和临床实践中的应用。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3012
Leonard Frach, Friederike S David, Markus M Nöthen, Andreas J Forstner
{"title":"Polygenic scores in psychiatric research and clinical practice.","authors":"Leonard Frach, Friederike S David, Markus M Nöthen, Andreas J Forstner","doi":"10.1515/medgen-2026-3012","DOIUrl":"10.1515/medgen-2026-3012","url":null,"abstract":"<p><p>Polygenic scores are nowadays common tools in psychiatric genetic research and are also increasingly applied in clinical settings. In this article, we give an overview of polygenic scores in psychiatric research, focusing on recent trends and novel applications such as using polygenic scores in family studies. Furthermore, we discuss use cases of polygenic scores in clinical studies and clinical practice, for instance using polygenic scores to predict treatment response to medication. While some challenges of polygenic scores are not unique to psychiatry (e.g. limited reliability or transferability across ancestries), we also highlight the specialties of using polygenic scores in psychiatric research and clinical practice (e.g. clinical and biological heterogeneity across and within psychiatric conditions), as well as limitations of other applications beyond research, e.g. using polygenic scores for psychiatric conditions for embryo selection. We further make the case for careful communication of genetics to patients and the general public. We conclude by providing an outlook which includes future directions and applications of polygenic scores in psychiatric research and clinical practice.</p>","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"199-210"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic risk scores in pharmacogenomics: methodological challenges, current applications, and perspectives for clinical implementation. 药物基因组学中的多基因风险评分：方法学上的挑战、当前的应用和临床实施的前景。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3013
Carina M Mathey, Martin Coenen, Ingolf Cascorbi, Per Hoffmann
{"title":"Polygenic risk scores in pharmacogenomics: methodological challenges, current applications, and perspectives for clinical implementation.","authors":"Carina M Mathey, Martin Coenen, Ingolf Cascorbi, Per Hoffmann","doi":"10.1515/medgen-2026-3013","DOIUrl":"10.1515/medgen-2026-3013","url":null,"abstract":"<p><p>Inter-individual variability in drug response remains a major challenge in clinical pharmacology. While clinical pharmacogenetics is largely based on actionable single-gene variants, increasing GWAS evidence indicates that many drug-response phenotypes are polygenic. Polygenic risk scores (PRS) offer a framework to capture cumulative effects across pharmacokinetic, pharmacodynamic, and disease-related pathways, enabeling probabilistic risk stratification beyond monogenic models. This review summarizes the current status of PRS in pharmacogenomics (PGx-PRS), highlighting key challenges including limited sample sizes of drug-exposed cohorts, heterogeneous phenotype definitions, ancestry-related portability issues, and incomplete representation of complex pharmacogenes such as <i>CPY2D6</i>. Current applications are discussed across cardiovascular, psychiatric, and oncological settings, where PRS show emerging potential for benefit-risk stratification but remain insufficiently validated for routine care. Clinical implementation will require standardized methodologies multi-ancestry validation, integration with rare-high impact ADME (Absorption, Distribution, Metabolism, and Excretion) variants, and clearer regulatory pathways. With these advances, PGx-PRS may become clinically relevant tools for precision prescribing and drug development.</p>","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"221-229"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic scores as modifiers in Mendelian diseases. 多基因评分作为孟德尔疾病的修饰因子。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3014
Henrike O Heyne, Kerstin U Ludwig, Axel Schmidt
{"title":"Polygenic scores as modifiers in Mendelian diseases.","authors":"Henrike O Heyne, Kerstin U Ludwig, Axel Schmidt","doi":"10.1515/medgen-2026-3014","DOIUrl":"10.1515/medgen-2026-3014","url":null,"abstract":"<p><p>Mendelian diseases are caused by rare pathogenic variants with large effects. However, phenotypes are often different between individuals carrying the same variant (\"variable expressivity\"), or even absent in some carriers (\"incomplete penetrance\"), suggesting that the genetic architecture of Mendelian diseases is more complex than previously thought. Common genetic variants are a potential modifier of observed phenotypes. Individual common variants usually have small effects, but in aggregate their effects can be substantial and be quantified as a polygenic score (PGS). The present review summarises available data on how PGS modify phenotypes in Mendelian diseases. We show that modifying effects of PGS on penetrance and expressivity have been observed in carriers of rare pathogenic variants across a broad range of conditions. This suggests that in Mendelian diseases, a modifying effect of the common variant background on penetrance and expressivity might be the rule rather than the exception. We anticipate that increasing data availability and methodological advances will improve our understanding of the genetic architecture of Mendelian diseases, including the joint consideration of both common and rare variants.</p>","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"231-239"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic risk scores in cancer. 癌症的多基因风险评分。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3011
Anja Tüchler, Laura Grohs, Alexander Volk, Stefan Aretz
{"title":"Polygenic risk scores in cancer.","authors":"Anja Tüchler, Laura Grohs, Alexander Volk, Stefan Aretz","doi":"10.1515/medgen-2026-3011","DOIUrl":"10.1515/medgen-2026-3011","url":null,"abstract":"<p><p>Polygenic risk scores (PRS) have emerged as a powerful tool to refine cancer risk prediction beyond age, family history, and modifiable environmental risk factors, enabling individualized prevention and early detection strategies. Evidence from breast, colorectal, and prostate cancer demonstrates that PRS significantly improve risk stratification in both sporadic and hereditary settings and can modify penetrance of pathogenic germline variants. Integrating PRS into multifactorial models such as CanRisk enhances predictive accuracy and supports risk-adapted preventive approaches. While implementation studies show feasibility, prospective validation and standardization as well as ancestry-specific calibration remain key challenges for clinical translation.</p>","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"187-198"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Klinische Bedeutung der genetischen Diagnostik bei ungewollter Kinderlosigkeit - Stellungnahme von BVDH und GfH zur geplanten EBM-Anpassung. 意外不育的遗传诊断的临床意义- BVDH和GfH对计划中的EBM适应的意见。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3006
{"title":"Klinische Bedeutung der genetischen Diagnostik bei ungewollter Kinderlosigkeit - Stellungnahme von BVDH und GfH zur geplanten EBM-Anpassung.","authors":"","doi":"10.1515/medgen-2026-3006","DOIUrl":"10.1515/medgen-2026-3006","url":null,"abstract":"","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"281-282"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Grußwort GfH-Jahrestagung 2027. 2027年年会论文集。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3019
{"title":"Grußwort GfH-Jahrestagung 2027.","authors":"","doi":"10.1515/medgen-2026-3019","DOIUrl":"10.1515/medgen-2026-3019","url":null,"abstract":"","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"277-278"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical utility of polygenic risk scores in cardiovascular disorders. 多基因风险评分在心血管疾病中的临床应用。
IF 1.4 4区 生物学
Medizinische Genetik Pub Date : 2026-07-08 eCollection Date: 2026-07-01 DOI: 10.1515/medgen-2026-3008
Heribert Schunkert, Ling Li, Teresa Trenkwalder
{"title":"Clinical utility of polygenic risk scores in cardiovascular disorders.","authors":"Heribert Schunkert, Ling Li, Teresa Trenkwalder","doi":"10.1515/medgen-2026-3008","DOIUrl":"10.1515/medgen-2026-3008","url":null,"abstract":"<p><p>The sudden and often fatal onset of many cardiovascular disease (CVD) calls for improved risk prediction and personalized preventive strategies. Polygenic risk score (PRS) captures inherited susceptibility and may add precision to guideline-recommended clinical risk score. Given the spectrum of CVD, the utility of PRS varies from being a clinically meaningful diagnostic tool to a scientific instrument that brings light into the complex aetiologies. This review summarizes the current understanding of PRS in CVD. We discuss methodological strategies for its construction and outline clinical scenarios for PRS across major CVDs, including coronary artery disease, aortic aneurysms, cardiomyopathies, atrial fibrillation in the context of heart failure, and hypertension, highlighting their potential to enhance risk stratification beyond traditional factors. Finally, we outline current knowledge gaps that limit the clinical implementation of PRS.</p>","PeriodicalId":51130,"journal":{"name":"Medizinische Genetik","volume":"38 3","pages":"177-186"},"PeriodicalIF":1.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13340638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书